Omeros Corporation

(OMER) Trade

By |

Profile

Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders.

Contact Information

Website: www.omeros.com
Main Phone: +1 206 676-5000
Address: 201 Elliott Avenue West
State: WA
City / Town: Seattle
Country: US
Postal Code: 98119

Issuer Information

Exchange: NSD
CEO: Gregory A. Demopulos
Employees: 258
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders.

Contact Information

Website: www.omeros.com
Main Phone: +1 206 676-5000
Address: 201 Elliott Avenue West
State: WA
City / Town: Seattle
Country: US
Postal Code: 98119

Issuer Information

Exchange: NSD
CEO: Gregory A. Demopulos
Employees: 258
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 19.94 $ 0.70 (3.64%)
Last Price 19.94 Change $ 0.70 Change % 3.64 Tick N/A
Bid 20.15 Bid Size 300.00 Ask 21.00 Ask Size 500.00
Open 19.70 High 20.53 Low 19.24 Prev Close 19.24
Last Trade Volume 1.2 mi 52 Wk Hi 25.46 52 Wk Low 8.50
Market Cap 1.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 61,652,326.00 EPS (TTM) -2.39 PE Ratio -8.30 Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 17
Number of Buys 3 12
Number of Sells 2 5
Net Activity 5000 166005
Last 10 Buys Shares
Peter A. Demopulos 1,000
Peter A. Demopulos 1,000
Ray Aspiri 1,000
Peter A. Demopulos 1,000
Arnold C. Hanish 1,000
Peter A. Demopulos 1,000
Peter A. Demopulos 1,000
Peter A. Demopulos 1,000
Last 10 Sell Shares
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Marcia S. Kelbon 1,000
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Michael A. Jacobsen 1,000
Thomas J. Cable 1,000
Thomas J. Cable 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 34 34 34 34
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 26.33 26.33 26.33 26.33
Standard Deviation 7.09 7.09 7.09 7.09
Date of Most Recent Estimate 05/17/18 05/17/18 05/17/18 05/17/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 3
Moderate Buy 0 0 0 0
Hold 2 2 2 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2 2 2 1.5